Polycystic ovarian syndrome is a health disorder that affects women from all races who are still under a productive age. The condition causes some considerable morbidity, so its symptoms start to appear amongst women in as early as during the beginning of menstruation. In other women, the condition develops during their early 20’s. Besides, its symptoms tend to appear as soon as your body begins to generate some hormonal imbalances. However, amongst the pre-disposing factors of contracting the disorder is being obese. According to Sabatini (2011), a polycystic ovarian syndrome is a combination of both the environmental as well as the genetic factors of women. The disorder is associated with a series of symptoms that collectively describe the underlying health condition in women. It includes; absence or irregular menstrual cycle in women, experiencing difficulties in getting pregnant as well as a situation whereby the skin develops some dark patches (Sabatini, 2011).
Other women tend to experience pain around their pelvic areas, excess growth of hair on the body, heavy menstrual, acne, and hair loss. Women living with the disorder are more susceptible to developing further health complications such as resistance to insulin, diabetes, cardiovascular disorders, abnormalities in lipid levels, and obstructive sleep apnea. According to Schroeder (2003), there is no clear definition of the disorder rather than the analysis that are projected towards the symptoms. As a result, clinical guidelines were developed to boost the safety and treatment measures of the disorder. Women who suspect that they are suffering from the disorder should be screened for non-classic congenital adrenal hyperplasia to ascertain their real conditions. Contrary to that, the a majority of women suffering from the disorder tend to develop sugar intolerance capabilities in their bodies and should, therefore, take the appropriate precautions to address their conditions (Schroeder, 2003).
Schroeder (2003) further argues that women suffering from the disorder should ensure that they go for dyslipidemia screening. The A screening will enable them to take precautions against lipoprotein that facilitates the development of cardiovascular diseases. Contrary to that, women suffering from the disorder are advised to use the pregnancy control pills and adopting ways of improving their insulin sensitivity levels. According to Schroeder (2003), minimizing disease disorders that go hand in hand with polycystic ovarian syndrome is most likely to boost the frequency of menstruation in women. On the other hand, women who may want to conceive should be advised to involve themselves in a lot of body exercises and weight control programs. However, should treatment be necessary, then clomiphene citrate would be an advisable medication because of its proved performance (Schroeder, 2003).
To assist in the management and treatment of patients with polycystic ovarian syndrome, the main focus should be directed towards ensuring that the patients are practicing healthy lifestyles (Miller & Farid, 2011). They should be given advice about the need of involving themselves in body exercise and weight maintenance programs. Furthermore, they should ensure that their diets balanced and free from cholesterol that may contribute to the development of lipoprotein. Apart from that, women with smoking habits should consider seizing from that. Women should also ensure that they seek frequent medical check-ups to discuss and ascertain their general health progress. Relevant governments and organizations should also help to facilitate the research and management programs that offer an upper hand in controlling the disorder. Online communities and forums should be developed to provide a platform for the patients to share their diverse experiences towards the disorder and the relevant way out. Volunteer programs should be adopted to conduct civic education to people who are not well informed about the disorder. Patients should also be guided on how to utilize the internet as a tool of acquiring any relevant information about polycystic ovarian syndrome. To ensure that our society is healthy, all health stakeholders including the public should open up research programs and general support against the common disease disorders that can be managed and controlled (Miller & Farid, 2011).
- Schroeder, B., M. (2003). ACOG Releases Guidelines on Diagnosis and Management of Polycystic Ovary Syndrome. Available at http://www.aafp.org/afp/2003/0401/p1619.html
- Miller, J., & Farid, N. (2011). The low GI guide to living well with PCOS: Lose weight, boost fertility and gain control over polycystic ovarian syndrome with the glycemic index. Cambridge, MA: Da Capo Press.
- Sabatini, R. (2011). Polycystic ovarian syndrome: An enigmatic endocrinological disorder. New York: Nova Biomedical Books.
